UK co-ordinating investigator international clinical trial: Idelalisib Combination Study GS-US-401-1757: A Phase 1b Dose Escalation and Dose Expansion Study of ONO/GS-4059 in Combination with other Targeted Anti-cancer Therapies in Subjects with B-cell Malignancies

Activity: Internal positions, career professional development, other peer review and otherOtherResearch

PeriodJul 2015Oct 2016
Held atGilead Sciences Europe Ltd, United Kingdom
Degree of RecognitionInternational